Relocated radioligand Opportunity to partner with InHealth Technologies on the UK relocatable radioligand therapy service launch. Potential for equipment provisioning, service contracts, and training support as they expand their oncology portfolio.

Voice restoration legacy Proven track record in tracheoesophageal puncture and Blom-Singer prostheses positions InHealth as a trusted vendor for ENT devices. Potential cross-sell of related consumables, maintenance, and aftercare products to otolaryngology clinics and rehabilitation centers.

Strategic partnerships History of institutional partnerships (Oxford University Hospitals, private education platforms) suggests a readiness for collaborative pilots, training programs, and integrated care solutions that could expand hospital networks and referral channels.

Growth through services Expansion into Day&Night HME and coaching academies indicates a diversification into patient support and home medical equipment. Opportunities exist for remote monitoring, coaching services, and value-based care programs that align with chronic disease prevention themes.

SMB collaboration Company size and revenue band imply mid-market healthcare partners and regional distributors as viable routes. Target medical distributors, clinics, and outpatient centers with scalable procurement needs for ENT and supportive care devices.